For a regulated or technically complex product, non-dilutive funding can pay for exactly the work investors are least keen to fund: feasibility, validation studies and early clinical evidence. It also signals that expert assessors have reviewed your science and backed it.
The catch is that grant applications are scored against specific criteria, deadlines are fixed, and most calls require match funding. Founders who write them alone often submit a strong science case that misses what assessors are actually asked to score, or commit to a project plan that does not line up with what their investors need to see next.
We treat a grant as part of your capital plan: which call, which work packages, which milestone it funds, and how it strengthens the story for your equity round.
Which current calls genuinely fit your technology, stage and timeline, and which to skip. Includes eligibility, match-funding needs and realistic timelines to award.
Shaping a project with clear objectives, work packages and deliverables that funds your next technical or clinical milestone and reads well to assessors.
Working with your technical team to write each section against the scoring criteria: the need, the innovation, the approach, the team, the market and the value for money.
Building a costed budget that stands up to scrutiny and aligning the match-funding requirement with your equity raise and cash-flow plan.
Identifying the academic, clinical or industry partners a strong application needs, and helping you secure letters of support.
Making sure the grant milestones, your regulatory pathway and your investor narrative all point in the same direction.
Programmes, eligibility rules and funding rates change with each round. We check the current terms of every call before recommending it. We cannot guarantee that any application will be funded, and we will tell you plainly if we think a call is not worth your time.
Our directors have raised over £12M for clients across equity rounds and grant applications, and have led the scientific, clinical and regulatory work that grant projects are built around, including CE marking and FDA clearance of AI medical products. That lets us write the technical and commercial sections with you, not just edit them.